All Type of News
Will it be ok to allow patients to purchase household medicines with no prescriptions?
Household medicines have become a trend. However, its following side effects have raised concerns as well.
According to the Statistics for Distribution Information of Complete Drugs published by the Health Insurance ...
Bill to expand the subject of rebate punishment to importers and exporters
A bill to expand the subject of rebate punishment to pharmaceutical product licensers, importers and exporters was proposed.
Assemblyperson Sung-joo Kim from the New Politics Alliance for Democracy(NPAD) proposed the...
Various usages of GLP-1 analogue from obesity to fatty liver
GLP-1 analogue, a diabetes treatment, has proved its effectiveness in various fields.
Obesity – The first is obesity. GLP-1 analogue, a incretin-based drug, has an advantage of reducing glycated hemoglobin(HbA1c) and...
Largest CSO establishment participated by pharmaceutical companies
The domestically largest CSO(Contract Sales Organizations) is about to be emerged in the pharmaceutical distribution industry.
According to the industry concerned on the 26th, a couple of pharmaceutical companies and...
Japanese pharmaceutical companies fighting well in outpatient prescription market
Japanese pharmaceutical companies have had upturns in the domestic outpatient prescription market. In particular, growths of pharmaceutical companies that have specialization strategies have stood out.
According to t...
‘Clear’ downtrends of major hypertension treatments
Downtrends of major hypertension treatments have become obvious.
It was observed only did 3 of 15 antihypertensive drugs have higher outpatient prescriptions in the 3rd quarter than the record of the last year.
Acco...
National Assembly Health and Welfare Committee to deliberate 2016 budgets
The National Assembly Health and Welfare Committee will hold a meeting for 3 days from the 26th and deliberate the 2016 budgets of the Ministry of Health and Welfare(MOHW) and the Ministry of Food and Drug Safety(MFDS...
‘1 Strong and 2 Medium’ positions in Celebrex generic market
In the market of ‘Celebrex(generic name: celecoxib), a selective COX-2 inhibitor anti-inflammatory drug, which was recognized as the most competitive market due to approximately 100 generic products launched, Chong Ku...
Mixed feelings of ETC drugs in actual output
The last year’s top 10 ETC drugs in annual sales had mixed feelings this year.
According to the ‘First Half’s Actual Outputs of Domestic ETC Drugs’ reported to the Ministry of Food and Drug Safety(MFDS), 6 of the top...
‘Lipitor’ in a great shape, getting away from the second largest one
In the hyperlipidemia field, Lipitor(developed by Pfizer) has remained strong. Its gap with Crestor, the second largest drug, has been expended since the beginning of the year.
Lipitor, which almost got caught, was a...
